Results 281 to 290 of about 180,771 (310)

Brentuximab vedotin and nivolumab for untreated patients with Hodgkin lymphoma: long-term results. [PDF]

Blood Adv
Cheson BD, Bartlett NL, Knopf B, Lee HJ, Advani RH, Christian B, Diefenbach CS, Feldman TA, Ansell SM.   +8 more
europepmc   +1 more source

Less may be enough: a transplant-free future for low-risk relapsed Hodgkin lymphoma. [PDF]

Transl Pediatr
Forlenza CJ, Castellino SM.
europepmc   +1 more source

Immunosenescence phenotypes and prognostic significance of CD8 + CD28- T cells in AIDS-related non-Hodgkin lymphoma. [PDF]

Ann Med
Kang Z, Tao X, Wu S, Chu S, Peng J, Chen J.   +5 more
europepmc   +1 more source

The Incidental Diagnosis of a Hodgkin Lymphoma Following Elective Robotic-Assisted Inguinal Hernia Repair: A Case Report. [PDF]

Cureus
Khan S, Boettge K, Jorge J.
europepmc   +1 more source

Coexistence of Tuberculous Lymphadenitis and Hodgkin Lymphoma: A Diagnostic Challenge. [PDF]

Cureus
Chandra M, Parmar M, Khilnani AK.
europepmc   +1 more source

Predicting thrombotic risk in patients with classical Hodgkin lymphoma: Thro-HL multicenter study. [PDF]

Hemasphere
Assanto GM, Alma E, Cellini A, Marsili G, Maiorana G, Santoro C, Salvatori M, Cenfra N, Otasevic V, Antic D, D'Elia GM, Bianchi MP, Annechini G, Ligia S, Pulsoni A, Tafuri A, Visentin A, Piciocchi A, Hohaus S, Martelli M, Del Giudice I, Chistolini A.   +21 more
europepmc   +1 more source